The benzodiazepine antagonist Ro 15-1788 does not antagonize the ethanol withdrawal syndrome

Bryon Adinoff, Edward Majchrowicz, Peter R. Martin, Markku Linnoila

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

It has been suggested that the signs and symptoms of the ethanol withdrawal syndrome may be due to the increased production of an "inverse agonist" that binds to the central benzodiazepine (BZ) recognition site in the brain. Ro 15-1788 (a potent antagonist at the central BZ recognition site), diazepam, and Ro 15-1788 plus diazepam were administered to groups of rats undergoing overt ethanol withdrawal. Ro 15-1788 did not alter the severity of the ethanol withdrawal reactions, but antagonized the ameliorative effect of diazepam. The results of our studies suggest that 1. (1) the ethanol withdrawal syndrome is not produced by an endogenous ligand acting on the central BZ recognition site, and 2. (2) diazepam decreases the severity of the ethanol withdrawal syndrome, at least in part, by its action at the central BZ recognition site.

Original languageEnglish (US)
Pages (from-to)643-649
Number of pages7
JournalBiological Psychiatry
Volume21
Issue number7
DOIs
StatePublished - 1986

Fingerprint

Flumazenil
Benzodiazepines
Diazepam
Ethanol
Signs and Symptoms
Ligands
Brain

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

The benzodiazepine antagonist Ro 15-1788 does not antagonize the ethanol withdrawal syndrome. / Adinoff, Bryon; Majchrowicz, Edward; Martin, Peter R.; Linnoila, Markku.

In: Biological Psychiatry, Vol. 21, No. 7, 1986, p. 643-649.

Research output: Contribution to journalArticle

Adinoff, Bryon ; Majchrowicz, Edward ; Martin, Peter R. ; Linnoila, Markku. / The benzodiazepine antagonist Ro 15-1788 does not antagonize the ethanol withdrawal syndrome. In: Biological Psychiatry. 1986 ; Vol. 21, No. 7. pp. 643-649.
@article{a328051c823f473d8af8978ee61454df,
title = "The benzodiazepine antagonist Ro 15-1788 does not antagonize the ethanol withdrawal syndrome",
abstract = "It has been suggested that the signs and symptoms of the ethanol withdrawal syndrome may be due to the increased production of an {"}inverse agonist{"} that binds to the central benzodiazepine (BZ) recognition site in the brain. Ro 15-1788 (a potent antagonist at the central BZ recognition site), diazepam, and Ro 15-1788 plus diazepam were administered to groups of rats undergoing overt ethanol withdrawal. Ro 15-1788 did not alter the severity of the ethanol withdrawal reactions, but antagonized the ameliorative effect of diazepam. The results of our studies suggest that 1. (1) the ethanol withdrawal syndrome is not produced by an endogenous ligand acting on the central BZ recognition site, and 2. (2) diazepam decreases the severity of the ethanol withdrawal syndrome, at least in part, by its action at the central BZ recognition site.",
author = "Bryon Adinoff and Edward Majchrowicz and Martin, {Peter R.} and Markku Linnoila",
year = "1986",
doi = "10.1016/0006-3223(86)90125-3",
language = "English (US)",
volume = "21",
pages = "643--649",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "7",

}

TY - JOUR

T1 - The benzodiazepine antagonist Ro 15-1788 does not antagonize the ethanol withdrawal syndrome

AU - Adinoff, Bryon

AU - Majchrowicz, Edward

AU - Martin, Peter R.

AU - Linnoila, Markku

PY - 1986

Y1 - 1986

N2 - It has been suggested that the signs and symptoms of the ethanol withdrawal syndrome may be due to the increased production of an "inverse agonist" that binds to the central benzodiazepine (BZ) recognition site in the brain. Ro 15-1788 (a potent antagonist at the central BZ recognition site), diazepam, and Ro 15-1788 plus diazepam were administered to groups of rats undergoing overt ethanol withdrawal. Ro 15-1788 did not alter the severity of the ethanol withdrawal reactions, but antagonized the ameliorative effect of diazepam. The results of our studies suggest that 1. (1) the ethanol withdrawal syndrome is not produced by an endogenous ligand acting on the central BZ recognition site, and 2. (2) diazepam decreases the severity of the ethanol withdrawal syndrome, at least in part, by its action at the central BZ recognition site.

AB - It has been suggested that the signs and symptoms of the ethanol withdrawal syndrome may be due to the increased production of an "inverse agonist" that binds to the central benzodiazepine (BZ) recognition site in the brain. Ro 15-1788 (a potent antagonist at the central BZ recognition site), diazepam, and Ro 15-1788 plus diazepam were administered to groups of rats undergoing overt ethanol withdrawal. Ro 15-1788 did not alter the severity of the ethanol withdrawal reactions, but antagonized the ameliorative effect of diazepam. The results of our studies suggest that 1. (1) the ethanol withdrawal syndrome is not produced by an endogenous ligand acting on the central BZ recognition site, and 2. (2) diazepam decreases the severity of the ethanol withdrawal syndrome, at least in part, by its action at the central BZ recognition site.

UR - http://www.scopus.com/inward/record.url?scp=0022531361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022531361&partnerID=8YFLogxK

U2 - 10.1016/0006-3223(86)90125-3

DO - 10.1016/0006-3223(86)90125-3

M3 - Article

VL - 21

SP - 643

EP - 649

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 7

ER -